Kristina Masson serves as Executive at Acrivon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kristina Masson has executed 14 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 21, 2025 involved selling 19,904 shares valued at $45.8K.
Kristina Masson currently holds 2,046,771 shares of Acrivon Therapeutics, Inc. (ACRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristina Masson has been a net neutral trader of ACRV stock. They have purchased $0 and sold $0 worth of shares.
Kristina Masson's most recent insider trade was on Nov 21, 2025, when they sold 19,904 shares at $2.30 per share.
Get notified when new Form 4 filings are submitted
| $2.24 |
| Discretionary |
| Nov 14, 2025 | ACRV | $1.1K | Payment | 490 | $2.24 | Discretionary |
| Aug 21, 2025 | ACRV | $26.3K | Payment | 19,905 | $1.32 | Discretionary |
| Aug 14, 2025 | ACRV | $83.1K | Payment | 59,766 | $1.39 | Discretionary |
| Aug 14, 2025 | ACRV | $681 | Payment | 490 | $1.39 | Discretionary |
| Aug 14, 2024 | ACRV | $3.4K | Payment | 490 | $7.02 | Discretionary |
| May 14, 2024 | ACRV | $4.1K | Payment | 490 | $8.36 | Discretionary |
| Feb 14, 2024 | ACRV | $2.0K | Payment | 579 | $3.40 | Discretionary |
| Nov 14, 2023 | ACRV | $9.7K | Payment | 1,900 | $5.08 | Discretionary |
| Nov 14, 2022 | ACRV | $0 | Award | 503,419 | $N/A | Discretionary |
| Nov 14, 2022 | ACRV | $0 | Award | 60,090 | $N/A | Discretionary |
| Nov 14, 2022 | ACRV | $0 | Award | 26,707 | $N/A | Discretionary |
| Nov 14, 2022 | ACRV | $0 | Award | 934,731 | $N/A | Discretionary |